Literature DB >> 12819970

Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

Peter Neuhaus1, Sven Jonas, Utz Settmacher, Armin Thelen, Christoph Benckert, Enrique Lopez-Hänninen, Rainer E Hintze.   

Abstract

BACKGROUND: Surgical resection provides the only chance of cure for patients suffering from hilar cholangiocarcinoma. Although appropriate procedures are not agreed upon, an increase in radicality has been observed during the past 20 years.
METHODS: The literature as well as our own experience after 133 resections of hilar cholangiocarcinomas were reviewed.
RESULTS: Tumor-free margins represent the most important prognostic parameter. Hilar resections as least radical resective procedure will generate rates of formally curative resections of less than 50%. Even after these formally curative resections, long-term survival cannot be achieved. Only additional liver resections will increase the number of long-term survivors to significant figures. In our series, the best 5-year survival rate of 72% was achieved after right trisegmentectomy with concomitant resection of the portal vein bifurcation.
CONCLUSION: Right trisegmentectomy and combined portal vein resection represent the best way to comply with basic rules of surgical oncology for hilar cholangiocarcinoma. This procedure will provide the most pronounced benefit among various types of liver resection, whereas local resections of the extrahepatic bile duct must be considered as an oncologically inefficient procedure.

Entities:  

Mesh:

Year:  2003        PMID: 12819970     DOI: 10.1007/s00423-003-0383-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  24 in total

1.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; Y Shimizu; A Kato; S Nakamura; H Omoto; N Nakajima; F Kimura; T Suwa
Journal:  Surgery       Date:  1998-02       Impact factor: 3.982

3.  Clinicopathologic studies on perineural invasion of bile duct carcinoma.

Authors:  M R Bhuiya; Y Nimura; J Kamiya; S Kondo; S Fukata; N Hayakawa; S Shionoya
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

Review 4.  Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.

Authors:  T Kosuge; J Yamamoto; K Shimada; S Yamasaki; M Makuuchi
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

5.  Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.

Authors:  Y Nimura; J Kamiya; S Kondo; M Nagino; K Uesaka; K Oda; T Sano; H Yamamoto; N Hayakawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

6.  S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.

Authors:  Y Kawarada; S Isaji; H Taoka; M Tabata; B C Das; H Yokoi
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

7.  Initial experience with a new Yamakawa-type prosthesis for long-term percutaneous transhepatic drainage.

Authors:  P Born; T Rösch; G Willkomm; W Sandschin; N Fitz; N Weigert; R Ott; E Frimberger; H Allescher; M Classen
Journal:  Endoscopy       Date:  1999-11       Impact factor: 10.093

8.  Pathological aspects of cholangiocarcinoma.

Authors:  K Weinbren; S S Mutum
Journal:  J Pathol       Date:  1983-02       Impact factor: 7.996

9.  Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization.

Authors:  T J Vogl; J O Balzer; K Dette; R Hintze; W Pegios; J Mäurer; H Keck; P Neuhaus; R Felix
Journal:  Radiology       Date:  1998-07       Impact factor: 11.105

10.  Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.

Authors:  Yuichiro Tojima; Masato Nagino; Tomoki Ebata; Katsuhiko Uesaka; Junichi Kamiya; Yuji Nimura
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more
  51 in total

Review 1.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

2.  Hepatic artery reconstruction first for the treatment of hilar cholangiocarcinoma bismuth type IIIB with contralateral arterial invasion: a novel technical strategy.

Authors:  Eduardo de Santibañes; Victoria Ardiles; Fernando A Alvarez; Juan Pekolj; Claudio Brandi; Axel Beskow
Journal:  HPB (Oxford)       Date:  2011-10-23       Impact factor: 3.647

3.  Improving outcomes in cholangiocarcinomas.

Authors:  Charles Imber; Justin Stebbing; Arjun Shankar
Journal:  Gastrointest Cancer Res       Date:  2011-09

Review 4.  Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma.

Authors:  Saleh Abbas; Charbel Sandroussi
Journal:  HPB (Oxford)       Date:  2013-01-08       Impact factor: 3.647

Review 5.  Current status of preoperative biliary drainage.

Authors:  Junko Umeda; Takao Itoi
Journal:  J Gastroenterol       Date:  2015-07-03       Impact factor: 7.527

6.  Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.

Authors:  Traian Dumitrascu; Dragos Chirita; Mihnea Ionescu; Irinel Popescu
Journal:  J Gastrointest Surg       Date:  2013-01-15       Impact factor: 3.452

7.  Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.

Authors:  Caitlin Hester; Ibrahim Nassour; Beverley Adams-Huet; Mathew Augustine; Michael A Choti; Rebecca M Minter; John C Mansour; Patricio M Polanco; Matthew R Porembka; Sam C Wang; Adam C Yopp
Journal:  J Gastrointest Surg       Date:  2018-07-20       Impact factor: 3.452

Review 8.  A review of systemic therapy in biliary tract carcinoma.

Authors:  Holger Jansen; Ulrich-Frank Pape; Nalân Utku
Journal:  J Gastrointest Oncol       Date:  2020-08

9.  Value of Multidetector-row Computed Tomography in Diagnosis of Portal Vein Invasion by Perihilar Cholangiocarcinoma.

Authors:  Teiichi Sugiura; Hideki Nishio; Masato Nagino; Yoshiki Senda; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Koji Oda; Yuji Nimura
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

Review 10.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.